| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Michael E Wechsler | |
| Paul M Szumita | |||
| Kevin E Anger | |||
| Steven A Baroletti | |||
| P2860 | cites work | Dexmedetomidine | Q73578516 |
| Management of the agitated intensive care unit patient | Q77627332 | ||
| Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care | Q24794921 | ||
| Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery | Q28199892 | ||
| Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects | Q28279789 | ||
| Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit | Q28377548 | ||
| Propofol and postoperative pancreatitis | Q30468067 | ||
| Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data | Q30936137 | ||
| ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens | Q33194243 | ||
| Sedation in the intensive care unit: a systematic review | Q33873070 | ||
| Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult | Q34119310 | ||
| The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome | Q34220515 | ||
| Propylene Glycol‐Associated Renal Toxicity from Lorazepam Infusion | Q34267218 | ||
| Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit | Q34313233 | ||
| Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. | Q34419506 | ||
| New agents for sedation in the intensive care unit | Q34474040 | ||
| Sedation assessment in critically ill adults | Q34495765 | ||
| Propofol infusion syndrome in critically ill patients | Q34797022 | ||
| Propofol: a review of its use in intensive care sedation of adults | Q35094646 | ||
| Six-month neuropsychological outcome of medical intensive care unit patients | Q35102021 | ||
| Propofol: an immunomodulating agent | Q36130653 | ||
| The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit | Q39379758 | ||
| Comparative sensitivity of a simulated driving task to self-report, physiological, and other performance measures during prolonged wakefulness. | Q39710915 | ||
| Patients requiring sedation. | Q40931844 | ||
| Delirium in an intensive care unit: a study of risk factors. | Q43712084 | ||
| Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit | Q43749433 | ||
| Bispectral index-guided sedation with dexmedetomidine in intensive care: a prospective, randomized, double blind, placebo-controlled phase II study | Q43990302 | ||
| Intensive care unit syndrome/delirium is associated with anemia, drug therapy and duration of ventilation treatment | Q44024334 | ||
| A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit | Q44320906 | ||
| Dexmedetomidine and cardiac arrest | Q44860948 | ||
| Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy. | Q45222693 | ||
| Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation | Q46488305 | ||
| Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors | Q46721377 | ||
| Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients | Q46880812 | ||
| The impact of delirium on the survival of mechanically ventilated patients. | Q47868425 | ||
| Delirium in the intensive care unit. | Q51019651 | ||
| Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge. | Q51464428 | ||
| P433 | issue | 1 | |
| P921 | main subject | intensive care unit | Q5094647 |
| P304 | page(s) | 37-44 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | American Journal of Health-System Pharmacy | Q15754037 |
| P1476 | title | Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine | |
| P478 | volume | 64 |
| Q41830212 | A comparative study of magnesium sulfate vs dexmedetomidine as an adjunct to epidural bupivacaine |
| Q38989882 | Analgesia in the surgical intensive care unit |
| Q34229516 | Analgosedation: a paradigm shift in intensive care unit sedation practice |
| Q34422961 | Can dexmedetomidine be a safe and efficacious sedative agent in post-cardiac surgery patients? a meta-analysis |
| Q40151876 | Clinical and economic impact of substituting dexmedetomidine for propofol due to a US drug shortage: examination of coronary artery bypass graft patients at an urban medical centre |
| Q92464202 | Comparision of Vital Surgical Parameters, after Administration of Midazolam and Dexmedetomidine for Conscious Sedation in Minor Oral Surgery |
| Q33981098 | Comparison of dexmedetomidine versus propofol for sedation in mechanically ventilated patients after cardiovascular surgery. |
| Q34201602 | Current practices of mobilization, analgesia, relaxants and sedation in Indian ICUs: A survey conducted by the Indian Society of Critical Care Medicine |
| Q37672839 | Dexmedetomidine as an adjunct to epidural analgesia after abdominal surgery in elderly intensive care patients: A prospective, double-blind, clinical trial |
| Q38131455 | Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research |
| Q58712045 | Dexmedetomidine in prevention and treatment of postoperative and intensive care unit delirium: a systematic review and meta-analysis |
| Q37389863 | Dexmedetomidine infusion for analgesia up to 48 hours after lung surgery performed by lateral thoracotomy. |
| Q87610491 | Dexmedetomidine is Associated with an Increased Incidence of Bradycardia in Patients with Trisomy 21 After Surgery for Congenital Heart Disease |
| Q48278198 | Dexmedetomidine: an alternative for epidural anesthesia in tension-free vaginal-tape surgery |
| Q36735205 | Dexmedetomidine: an updated review |
| Q57807451 | Effect of perioperative infusion of Dexmedetomidine combined with Sufentanil on quality of postoperative analgesia in patients undergoing laparoscopic nephrectomy: a CONSORT-prospective, randomized, controlled trial |
| Q37885734 | Evaluation of a local ICU sedation guideline on goal-directed administration of sedatives and analgesics |
| Q42095957 | Evaluation of the impact of a prescribing guideline on the use of intraoperative dexmedetomidine at a tertiary academic medical center |
| Q38167005 | Implementation of a dexmedetomidine stewardship program at a tertiary academic medical center |
| Q40211980 | Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine |
| Q26994769 | Interpatient variability in dexmedetomidine response: a survey of the literature |
| Q37169834 | Medications for analgesia and sedation in the intensive care unit: an overview |
| Q30360161 | Perioperative pain management. |
| Q41999985 | Preliminary experience with dexmedetomidine in neonatal anesthesia |
| Q47166527 | Risk Factors of Delirium in Sequential Sedation Patients in Intensive Care Units |
| Q38110444 | Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients |
| Q38099608 | Role of dexmedetomidine in adults in the intensive care unit: an update |
| Q37869277 | Role of α2-agonists in the treatment of acute alcohol withdrawal |
| Q37867302 | Sedation and analgesia in critically ill neurologic patients |
| Q35980684 | The Influence of Perioperative Dexmedetomidine on Patients Undergoing Cardiac Surgery: A Meta-Analysis |
| Q58720563 | The efficacy and safety of dexmedetomidine in cardiac surgery patients: A systematic review and meta-analysis |
| Q37802588 | Understanding and Managing Patients with Chronic Pain |
| Q81565636 | [Clinical practice guideline based on the evidence for the management of sedoanalgesia in the critically ill adult patient] |
| Q88917289 | [Pain therapy in intensive care patients] |
Search more.